Protein biomarkers in cancer: Natural glycoprotein microarray approaches

Current Opinion in Molecular Therapeutics

Volumn 10, Issue 6, 2008, Pages 602-610

  Zhao, J ^a   Patwa, T H ^a   Lubman, D M ^a   Simeone, D M ^a  

^a UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

Author keywords

Carbohydrate microarray; Glycoprotein microarray; Glycosylation; Lectin; Lectin microarray

Indexed keywords

CARBOHYDRATE; CONCANAVALIN A; GLYCAN; GLYCOPROTEIN; HEPARIN BINDING PROTEIN; HUMAN IMMUNODEFICIENCY VIRUS VACCINE; JACALIN; LECTIN; WHEAT GERM AGGLUTININ;

AFFINITY CHROMATOGRAPHY; BIOTINYLATION; BREAST CANCER; CANCER DIAGNOSIS; CANCER INVASION; CANCER PATIENT; CARBOHYDRATE MICROARRAY; CHRONIC LIVER DISEASE; COLORECTAL CANCER; DIGESTIVE SYSTEM CANCER; DISEASE COURSE; EARLY DIAGNOSIS; ENZYME ACTIVITY; ENZYME ASSAY; FUCOSYLATION; GLYCOPROTEIN MICROARRAY; HUMAN; LECTIN MICROARRAY; LIVER CELL CARCINOMA; METASTASIS; NEOPLASM; PANCREAS CANCER; PROSTATE CANCER; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN GLYCOSYLATION; PROTEIN INTERACTION; PROTEIN MICROARRAY; PROTEIN MODIFICATION; PROTEIN STRUCTURE; REPRODUCIBILITY; REVIEW; SENSITIVITY AND SPECIFICITY; SIALYLATION; TUMOR GROWTH;

ANIMALS; GLYCOPROTEINS; GLYCOSYLATION; HUMANS; LECTINS; MODELS, BIOLOGICAL; NEOPLASMS; PROTEIN ARRAY ANALYSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 57349086392     PISSN: 14648431     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (54)

1. Bertozzi CR, Kiessling LL: Chemical glycobiology. Science (2001) 291(5512):2357-2364. • This review provides a detailed explanation of the importance of glycobiology in the modulation of key cellular processes. It also describes chemically how such processes can be probed using synthetic strategies and how they can be applied for potential therapeutic-type applications.
2. Rudd PM, Elliott T, Cresswell P, Wilson IA, Dwek RA: Glycosylation and the immune system. Science (2001) 291(5512):2370-2376.
3. Osawa T, Tsuji T: Fractionation and structural assessment of oligosaccharides and glycopeptides by use of immobilized lectins. Annu Rev Biochem (1987) 56:21-42.
4. Durand G, Seta N: Protein glycosylation and diseases: Blood and urinary oligosaccharides as markers for diagnosis and therapeutic monitoring. Clin Chem (2000) 46(6):795-805.
5. Zhao J, Simeone DM, Heidt D, Anderson MA, Lubman DM: Comparative serum glycoproteomics using lectin selected sialic acid glycoproteins with mass spectrometric analysis: Application to pancreatic cancer serum. J Proteome Res (2006) 5(7):1792-1802.
6. Peracaula R, Royle L, Tabares G, Mallorqui-Fernández G, Barrabés S, Harvey DJ, Dwek RA, Rudd PM, de Llorens R: Glycosylation of human pancreatic ribonuclease: Differences between normal and tumor states. Glycobiology (2003) 13(4):227-244.
7. Zhao J, Qiu W, Simeone DM, Lubman DM: N-linked glycosylation profiling of pancreatic cancer serum using capillary liquid phase separation coupled with mass spectrometric analysis. J Proteome Res (2007) 6(3):1126-1138.
8. Kobata A, Amano J: Altered glycosylation of proteins produced by malignant cells, and application for the diagnosis and immunotherapy of tumours. Immunol Cell Biol (2005) 83(4):429-439.
9. Dube DH, Bertozzi CR: Glycans in cancer and inflammation - potential for therapeutics and diagnostics. Nat Rev Drug Discov (2005) 4(6):477-488.
10. An HJ, Miyamoto S, Lancaster KS, Kirmiz C, Li B, Lam KS, Leiserowitz GS, Lebrilla CB: Profiling of glycans in serum for the discovery of potential biomarkers for ovarian cancer. J Proteome Res (2006) 5(7):1626-1635.
11. Peracaula R, Tabarés G, Royle L, Harvey DJ, Dwek RA, Rudd PM, de Llorens R: Altered glycosylation pattern allows the distinction between prostate-specific antigen (PSA) from normal and tumor origins. Glycobiology (2003) 13(6):457-470.
12. Kasbaoui L, Harb J, Bernard S, Meflah K: Differences in glycosylation state of fibronectin from two rat colon carcinoma cell lines in relation to tumoral progressiveness. Cancer Res (1989) 49(19):5317-5322.
13. Kellokumpu S, Sormunen R, Kellokumpu I: Abnormal glycosylation and altered Golgi structure in colorectal cancer: Dependence on intra-golgi pH. FEBS Lett (2002) 516(1-3):217-224.
14. Ng RC, Roberts AN, Wilson RG, Latner AL, Turner GA: Analyses of protein extracts of human breast cancers: Changes in glycoprotein content linked to the malignant phenotype. Br J Cancer (1987) 55(3):249-254.
15. Orntoft TF, Vestergaard EM: Clinical aspects of altered glycosylation of glycoproteins in cancer. Electrophoresis (1999) 20(2):362-371. •• A variety of changes to O- and N-linked glycoproteins observed in cancer cells are described. Mechanisms by which glycoproteins interact and can be potentially controlled are also discussed.
16. Duffy MJ: CA 19-9 as a marker for gastrointestinal cancers: A review. Ann Clin Biochem (1998) 35(3):364-370.
17. Ferretti G, Felici A, Papaldo P, Fabi A, Cognetti F: Her2/neu role in breast cancer: From a prognostic foe to a predictive friend. Curr Opin Obstet Gynecol (2007) 19(1):56-62.
18. Demetriou M, Nabi IR, Coppolino M, Dedhar S, Dennis JW: Reduced contact-inhibition and substratum adhesion in epithelial cells expressing GlcNAc-transferase V. J Cell Biol (1995) 130(2):383-392.
19. Patwa TH, Zhao J, Anderson MA, Simeone DM, Lubman DM: Screening of glycosylation patterns in serum using natural glycoprotein microarrays and multi-lectin fluorescence detection. Anal Chem (2006) 78(18):6411-6421. • Initial studies in which naturally occurring glycoprotein arrays were probed with lectins to detect changes in glycosylation that may be occurring as a function of disease were described. The experimental design is of particular interest as novel changes could potentially be detected using the approach; such changes may not be highlighted in an antibody array if an antibody of a potentially novel candidate is not present.
20. Orntoft TF, Greenwell P, Clausen H, Watkins WM: Regulation of the oncodevelopmental expression of type 1 chain ABH and Lewis(b) blood group antigens in human colon by α-2-L-fucosylation. Gut (1991) 32(3):287-293.
21. Ang IL, Poon TC, Lai PB, Chan AT, Ngai SM, Hui AY, Johnson PJ, Sung JJ: Study of serum haptoglobin and its glycoforms in the diagnosis of hepatocellular carcinoma: A glycoproteomic approach. J Proteome Res (2006) 5(10):2691-2700.
22. Burchell JM, Mungul A, Taylor-Papadimitriou J: O-linked glycosylation in the mammary gland: Changes that occur during malignancy. J Mammary Gland Biol Neoplasia (2001) 6(3):355-364.
23. Muller S, Hanisch FG: Recombinant MUC1 probe authentically reflects cell-specific O-glycosylation profiles of endogenous breast cancer mucin. High density and prevalent core 2-based glycosylation. J Biol Chem (2002) 277(29):26103-26112.
24. Dall'Olio F, Chiricolo M: Sialyltransferases in cancer. Glycoconj J (2001) 18(11-12):841-850.
25. Drake RR, Schwegler EE, Malik G, Diaz J, Block T, Mehta A, Semmes OJ: Lectin capture strategies combined with mass spectrometry for the discovery of serum glycoprotein biomarkers. Mol Cell Proteomics (2006) 5(10):1957-1967.
26. Yang Z, Harris LE, Palmer-Toy DE, Hancock WS: Multilectin affinity chromatography for characterization of multiple glycoprotein biomarker candidates in serum from breast cancer patients. Clin Chem (2006) 52(10):1897-1905.
27. Qiu R, Regnier FE: Comparative glycoproteomics of N-linked complex-type glycoforms containing sialic acid in human serum. Anal Chem (2005) 77(22):7225-7231. •• This study described an emerging technique that used glycoprotein enrichment and separation in the liquid phase. This facilitated easy coupling to MS, the method of choice to characterize glycopeptides and glycoproteins.
28. Madera M, Mechref Y, Novotny MV: Combining lectin microcolumns with high-resolution separation techniques for enrichment of glycoproteins and glycopeptides. Anal Chem (2005) 77(13):4081-4090. • This study described the use of lectin columns to isolate proteins with specific glycan structures. The column characteristics and the use of HPLC in such enrichment and high-resolution separation are described in great depth.
29. Nimrichter L, Gargir A, Gortler M, Altstock RT, Shtevi A, Weisshaus O, Fire E, Dotan N, Schnaar RL: Intact cell adhesion to glycan microarrays. Glycobiology (2004) 14(2):197-203. • This study described one method in which glycoprotein function can be investigated using a microarray approach. In particular, glycan arrays were used to monitor cellular adhesion. Extension of this method to CD4+ human T-cells on a 45-glycan diversity array revealed interesting adhesion patterns to very specific Lewis structures.
30. Wang D, Lu J: Glycan arrays lead to the discovery of autoimmunogenic activity of SARS-CoV. Physiol Genomics (2004) 18(2):245-248.
31. Feizi T, Fazio F, Chai W, Wong CH: Carbohydrate microarrays - A new set of technologies at the frontiers of glycomics. Curr Opin Struct Biol (2003) 13(5):637-645.
32. Huang CY, Thayer DA, Chang AY, Best MD, Hoffmann J, Head S, Wong CH: Carbohydrate microarray for profiling the antibodies interacting with Globo H tumor antigen. Proc Natl Acad Sci USA (2006) 103(1):15-20.
33. Manimala JC, Li Z, Jain A, VedBrat S, Gildersleeve JC: Carbohydrate array analysis of anti-Tn antibodies and lectins reveals unexpected specificities: Implications for diagnostic and vaccine development. Chembiochem (2005) 6(12):2229-2241.
34. Stevens J, Blixt O, Paulson JC, Wilson IA: Glycan microarray technologies: Tools to survey host specificity of influenza viruses. Nat Rev Microbiol (2006) 4(11):857-864.
35. Adams EW, Ratner DM, Bokesch HR, McMahon JB, O'Keefe BR, Seeberger PH: Oligosaccharide and glycoprotein microarrays as tools in HIV glycobiology; glycan-dependent gp120/protein interactions. Chem Biol (2004) 11(6):875-881.
36. Disney MD, Magnet S, Blanchard JS, Seeberger PH: Aminoglycoside microarrays to study antibiotic resistance. Angew Chem Int Ed Engl (2004) 43(12):1591-1594.
37. de Paz JL, Noti C, Seeberger PH: Microarrays of synthetic heparin oligosaccharides. J Am Chem Soc (2006) 128(9):2766-2767.
38. Feizi T: Progress in deciphering the information content of the 'glycome' - A crescendo in the closing years of the millennium. Glycoconj J (2000) 17(7-9):553-565.
39. Wang D, Liu S, Trummer BJ, Deng C, Wang A: Carbohydrate microarrays for the recognition of cross-reactive molecular markers of microbes and host cells. Nat Biotechnol (2002) 20(3):275-281.
40. CFG Nature: Functional glycomics gateway: Consortium for functional glycomics. The Scripps Research Institute, La Jolla, CA, USA (2008). www.functionalglycomics.org/static/consortium/consortium.shtml
41. Hsu KL, Mahal LK: A lectin microarray approach for the rapid analysis of bacterial glycans. Nat Protoc (2006) 1(2):543-549.
42. Pilobello KT, Krishnamoorthy L, Slawek D, Mahal LK: Development of a lectin microarray for the rapid analysis of protein glycopatterns. Chembiochem (2005) 6(6):985-989.
43. Kuno A, Uchiyama N, Koseki-Kuno S, Ebe Y, Takashima S, Yamada M, Hirabayashi J: Evanescent-field fluorescence-assisted lectin microarray: A new strategy for glycan profiling. Nat Methods (2005) 2(11):851-856.
44. Uchiyama N, Kuno A, Koseki-Kuno S, Ebe Y, Horio K, Yamada M, Hirabayashi J: Development of a lectin microarray based on an evanescent-field fluorescence principle. Methods Enzymol (2006) 415:341-351.
45. Rosenfeld R, Bangio H, Gerwig GJ, Rosenberg R, Aloni R, Cohen Y, Amor Y, Plaschkes I, Kamerling JP, Maya RB: A lectin array-based methodology for the analysis of protein glycosylation. J Biochem Biophys Methods (2007) 70(3):415-426.
46. Yan F, Sreekumar A, Laxman B, Chinnaiyan AM, Lubman DM, Barder TJ: Protein microarrays using liquid phase fractionation of cell lysates. Proteomics (2003) 3(7):1228-1235.
47. Gembitsky DS, Lawlor K, Jacovina A, Yaneva M, Tempst P: A prototype antibody microarray platform to monitor changes in protein tyrosine phosphorylation. Mol Cell Proteomics (2004) 3(11):1102-1118.
48. Tomizaki KY, Usui K, Mihara H: Protein-detecting microarrays: Current accomplishments and requirements. Chembiochem (2005) 6(5):782-799.
49. Angeloni S, Ridet JL, Kusy N, Gao H, Crevoisier F, Guinchard S, Kochhar S, Sigrist H, Sprenger N: Glycoprofiling with micro-arrays of glycoconjugates and lectins. Glycobiology (2005) 15(1):31-41.
50. Hanisch FG, Hanski C, Hasegawa A: Sialyl Lewisx antigen as defined by monoclonal antibody AM-3 is a marker of dysplasia in the colonic adenoma-carcinoma sequence. Cancer Res (1992) 52(11):3138- 3144.
51. Lucka L, Fernando M, Grunow D, Kannicht C, Horst AK, Nollau P, Wagener C: Identification of Lewis x structures of the cell adhesion molecule CEACAM1 from human granulocytes. Glycobiology (2005) 15(1):87-100.
52. Chen S, Laroche T, Hamelinck D, Bergsma D, Brenner D, Simeone D, Brand RE, Haab BB: Multiplexed analysis of glycan variation on native proteins captured by antibody microarrays. Nat Methods (2007) 4(5):437-444. • This study described the use of an antibody array to highlight critical glycosylation differences in cancer. Such an experimental scheme is particularly interesting because both protein abundance as well as specific glycan changes can be monitored on the same microarray by using difference detection schemes.
53. Zhao J, Patwa TH, Qiu W, Shedden K, Hinderer R, Misek DE, Anderson MA, Simeone DM, Lubman DM: Glycoprotein microarrays with multi-lectin detection: Unique lectin binding patterns as a tool for classifying normal, chronic pancreatitis and pancreatic cancer sera. J Proteome Res (2007) 6(5):1864-1874.
54. Qiu Y, Patwa TH, Xu L, Shedden K, Misek DE, Tuck M, Jin G, Ruffin MT, Turgeon DK, Synal S, Bresalier R et al: Plasma glycoprotein profiling for colorectal cancer biomarker identification by lectin glycoarray and lectin blot. J Proteome Res (2008) 7(4):1693-1703.